In NObCAD, CAC is present in more than half of patients and is associated with both plaque burden and cardiovascular risk factors, supporting the role of CAC as a surrogate marker of subclinical atherosclerosis progression.
Abstract
Abstract Background: The prognostic value of coronary artery calcium (CAC) score in nonobstructive coronary artery disease (NObCAD; stenosis < 50%) remains insufficiently characterized. Objectives: To investigate the association between CAC score, cardiovascular risk factors, and clinical outcomes in patients with NObCAD. Methods: A total of 2,509 patients underwent coronary computed tomography angiography (CTA) and were followed for 8.9 ± 2.6 years. Plaque burden was classified according to CAD-RADS™ 2.0 into none, mild, moderate, and high/highest. The primary endpoint (PEP) was a composite of all-cause mortality, acute coronary syndrome/acute myocardial infarction, and stroke. Statistical significance was set at 5%. Results: CAC score was 0 in 45.4% of patients, 1-99 in 36.6%, and ≥ 100 in 18.0%. Correspondingly, 38.3% of patients had no coronary lesions, 38.5% had mild lesions, 14.1% had moderate lesions, and 9.2% had high/highest lesions. Among patients with CAC = 0, the absence of coronary lesions predominated (81.2%), whereas it was rare among those with CAC ≥ 100. The PEP occurred in 4.9% of patients, predominantly driven by all-cause mortality. Among the 396 patients with serial coronary CTA (mean interval: 6.5 ± 2.6 years), CAC progression (> 2.5 increase based on the square root method) was observed in 41.9%. Plaque burden increased in parallel. CAC score showed a positive association with plaque burden and cardiovascular risk factors. Conclusions: In NObCAD, CAC is present in more than half of patients and is associated with both plaque burden and cardiovascular risk factors. The incidence of PEP increases in proportion to risk factor burden and CAC levels. CAC and plaque burden progress concurrently over time, supporting the role of CAC as a surrogate marker of subclinical atherosclerosis progression.
The risk factors of developing a CTO are similar to those of coronary artery disease. This study investigates the risk factors and clinical profiles of patients with CTO.
A retrospective cohort study was conducted at dr. Kariadi Central Hospital Semarang. Medical records of CTO patients who underwent coron...
M. Fatchi, H. Cantika, H. Satoto· European Heart Journal, Supp...· 0 citations
BACKGROUND
The influence of sex on coronary inflammation in patients with non-obstructive coronary artery disease (CAD) remains unclear. This study aims to determine sex differences in coronary inflammation, quantified by pericoronary fat attenuation index (pFAI) derived from coronary computed tomography angiography (C...
Bo-Wen Li, Yong Chen, Xue-Qiao Yang et al.· European Heart Journal - Qua...· 0 citations
Background: The absence of coronary artery calcium (CAC = 0) on computed tomography (CT) portends a low but not zero coronary risk. However, the frequency and prognostic significance of non-calcified plaques in CAC = 0 patients are incompletely defined, and non-coronary artery disease (CAD) causes of coronary risk have...
Jeffrey L. Anderson, Leslie K. Iverson, Daniel L. Bride et al.· Journal of Clinical Medicine· 0 citations
BACKGROUND
The coronary artery calcium score (CACS) has strong prognostic value in stable chest pain patients. However, studies with follow-up beyond 5 years are scarce. We studied the long-term prognosis of CACS beyond pre-test probability (PTP) and single-photon emission computed tomography (SPECT) results for major...
M. Kamerman, J. V. van Dijk, J. Timmer et al.· Journal of cardiovascular co...· 0 citations
Introduction: Coronary computed tomography angiography (CCTA) is a noninvasive test for suspected coronary artery disease (CAD), but the prognostic value of integrating plaque burden into CAD-RADS 2.0 has not been fully evaluated. We aimed to assess whether the high-risk CAD-RADS 2.0 category, which combines stenosis s...
A. Ezponda, J. M. Rodríguez, M. Sogbe et al.· Medical Science· 0 citations
In patients with ST‐T changes, LVGLS, male sex, and typical chest pain independently predict the presence of CAD, while LVGLS is also strongly associated with disease severity.